Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS
Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS
This study was designed to assess the effectiveness of dutasteride in the actual clinical
 practice of prostate assessment clinics in the UK in accordance with best practice over a
 12-month period.
Inclusion Criteria:

 -  Patients who not have received any pharmacological treatment or surgical interventions
 for BPH (Benign Prostatic Hyperplasia).

 -  Patients should be prescribed dutasteride in compliance with the UK SmPC and BAUS
 guidelines on the treatment of BPH.

 -  Patients must only enter the study after the decision to prescribe dutasteride has
 been undertaken.

 Exclusion criteria: None specified